Antalgic Effects of Well-being Treatments in Cancer Care (Well Being)

Antalgic Effects of Well-being Treatments in Cancer Care; Foot Reflexology, Socio-aesthetics, Sophrology, Singing

observational , Monocentric, study to assess antalgic effects of well-being treatment in cancer care.

Study Overview

• Status: Completed
• Conditions: Cancer; Cancer Pain

Detailed Description

Contrary to supportive care, well-being care is imperfectly assessed. Well being care (WBC) consist on complementary programs, with no real consensus. Very few studies have rigorously evaluated its benefits

The objective of this study was to evaluate the impact of four well-being treatments (foot reflexology, socio-aesthetics, Sophrology and singing) provided in a healthcare facility

• Study Type: Observational
• Enrollment (Actual): 180

Contacts and Locations

Study Locations

• France
  • Drome
    • Valence, Drome, France, 26953
      • CH Valence

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 14 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: No

• Sampling Method: Non-Probability Sample

Study Population

patients treated for a cancer in CH Valence, agree to participate on one of the 4 Well being treatments: foot reflexology, socio-aesthetics, sophrology and singing

Description

Inclusion Criteria:

• all type of cancer treated at the general Hospital of Valence
• patient agree to participate on Well being session: foot reflexology, socio-aesthetics, Sophrology and singing
• Age ≥ 18 years
• Affiliation to a Social security system
• Patient who has given written consent signed before any specific procedure of the protocol

Exclusion Criteria:

• Patient under guardianship, deprived of liberty, safeguard of justice
• Patient presenting a serious psychiatric pathology that does not allow compliance with the completion of the scale (at the discretion of the investigator)
• Refusal to participate in research

Study Plan

How is the study designed?

Design Details

• Observational Models: Cohort
• Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Pain assesment	numerical scale 0 to 10, with 0 being "no pain" and 10 being "the worst pain imaginable."	1 immediately before well being treatment
Pain assesment	numerical scale 0 to 10, with 0 being "no pain" and 10 being "the worst pain imaginable."	1 immediately after well being treatment

Collaborators and Investigators

• Sponsor: Centre Hospitalier de Valence

Study record dates

Study Major Dates

• Study Start (Actual): January 22, 2020
• Primary Completion (Actual): September 30, 2021
• Study Completion (Actual): December 30, 2021

Study Registration Dates

• First Submitted: July 6, 2022
• First Submitted That Met QC Criteria: August 5, 2022
• First Posted (Actual): August 9, 2022

Study Record Updates

• Last Update Posted (Estimated): September 8, 2025
• Last Update Submitted That Met QC Criteria: September 5, 2025
• Last Verified: September 1, 2025

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Pain; Neurologic Manifestations; Pathological Conditions, Signs and Symptoms; Signs and Symptoms; Cancer Pain; Neoplasms
• Other Study ID Numbers: RIPH-CHV-04

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: UNDECIDED

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No